TARA- Protara Therapeutics, Inc.

Name: Protara Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Protara Therapeutics, Inc. (TARA) has 14 insiders with recent SEC Form 4 filings, including 24 buys and 0 sells. TARA is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Shefferman Jesse	524.0K	$2.79M	-
CFO	Fabbio Patrick	175.0K	$930.1K	-
Other	Nicacio Leonardo Viana	158.0K	$839.8K	-
Other	Zummo Jacqueline	94.8K	$504.0K	-
Other	Conkling William	76.0K	$403.9K	-

Activity

Buys and sells only

Transactions

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 10, 2022	Beshar Luke M	Director	Buy	10,000	$4.46	$44,555.00	+6.0%	-22.6%	-27.9%
Jan 28, 2022	Opaleye Management Inc.59	10% Owner	Buy	24,031	$4.96	$119,270.66	+0.9%	-25.3%	-38.6%
Dec 29, 2021	Opaleye Management Inc.59	10% Owner	Buy	11,591	$6.60	$76,498.00	+0.4%	-14.1%	-55.1%
Dec 27, 2021	Opaleye Management Inc.59	10% Owner	Buy	38,000	$6.53	$248,293.39	+0.7%	-16.9%	-57.9%
Dec 20, 2021	Opaleye Management Inc.59	10% Owner	Buy	703	$6.49	$4,562.47	-	-25.7%	-57.6%
Dec 17, 2021	Opaleye Management Inc.59	10% Owner	Buy	10,353	$6.46	$66,898.88	+0.2%	-25.2%	-54.3%
Nov 18, 2021	Opaleye Management Inc.59	10% Owner	Buy	24,324	$6.98	$169,773.92	+0.5%	-24.2%	-53.0%
Nov 4, 2021	Opaleye Management Inc.59	10% Owner	Buy	6,557	$6.50	$42,620.50	+0.3%	-22.4%	-59.5%
Jun 10, 2021	Olivo Martin Sebastian	Chief Medical Officer	Buy	9,893	$10.10	$99,968.14	+71.4%	-23.9%	-67.5%
Sep 30, 2020	Opaleye Management Inc.59	10% Owner	Buy	50,000	$16.00	$800,000.00	+2.1%	-	-

← PrevPage 3Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC